Rx Pricing Plan Offered By FDA’s McClellan; Industry Must Meet “Challenge”
Executive Summary
The pharmaceutical industry must "work harder" to establish equitable pricing models, FDA Commissioner McClellan declared during a Sept. 25 address to the First International Colloquium on Generic Medicine in Cancun, Mexico
You may also be interested in...
International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations
U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement
International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations
U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement
Rx Pricing And Trade Subject Of FDA, Industry Meeting With House Leader
House Speaker Dennis Hastert (R-Ill.) plans to work with the pharmaceutical industry and trade officials to deliver "fairer" drug prices in the U.S